Progression of Pulmonary Mycobacteriosis Caused by M. avium after Recovery from COVID-19: a Case Report
- 作者: Dobin V.L.1, Nikolaev A.N.1
-
隶属关系:
- Ryazan State Medical University
- 期: 卷 33, 编号 2 (2025)
- 页面: 269-276
- 栏目: Clinical reports
- ##submission.dateSubmitted##: 14.12.2023
- ##submission.dateAccepted##: 14.02.2024
- ##submission.datePublished##: 02.07.2025
- URL: https://journals.eco-vector.com/pavlovj/article/view/624559
- DOI: https://doi.org/10.17816/PAVLOVJ624559
- EDN: https://elibrary.ru/QDONBT
- ID: 624559
如何引用文章
详细
INTRODUCTION: At the present time, the importance of the problem of co-infection of tuberculosis and coronavirus disease-19, COVID-19, has already been recognized and is being studied systematically, and the significance of the combination of pulmonary mycobacteriosis and COVID-19 is only being recognized, as evidenced by descriptions of single cases.
AIM: To demonstrate the influence of COVID-19 on the clinical course of pulmonary mycobacteriosis.
A clinical case of a 38-year-old female patient is presented with oligosymptomatic progression of pulmonary mycobacteriosis caused by M. avium, at 6 months after recovery from COVID-19. Mycobacteriosis developed with the underlying anomaly in the form of the right-sided aortic arch complicated by compression stenosis of trachea and bronchiectasis of S4, S5 segments of the left lung.
CONCLUSION: Patients with mycobacteriosis require active follow-up after recovery from COVID-19 for at least a year, for timely diagnosis of reactivation and treatment of pulmonary mycobacteriosis.
全文:

作者简介
Vitaliy Dobin
Ryazan State Medical University
Email: viladob@gmail.com
ORCID iD: 0000-0002-6512-558X
SPIN 代码: 7954-9457
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, RyazanAleksey Nikolaev
Ryazan State Medical University
编辑信件的主要联系方式.
Email: nalex12@mail.ru
ORCID iD: 0000-0002-3625-602X
SPIN 代码: 4748-5421
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Ryazan参考
- Uryas’yev OM, Solov’yeva AV, Smaznova OA, et al. Analysis of the Interrelation between Clinical, Laboratory and Radiological Characteristics of Patients with COVID-19 Depending on the Outcome. Science of the Young (Eruditio Juvenium). 2024;12(4):501–511. doi: 10.23888/HMJ2024124501-511 EDN: MRWMZF
- Dashi E, Vahdani B, Chepure A, et al. Characteristic Features of Impact of COVID-19 Pandemics on Mental Health of Population of Different Countries: Results of Cross-Sectional Online Studies in Albania, India, Iran and Nigeria. I.P. Pavlov Russian Medical Biological Herald. 2022;30(3): 335–344. doi: 10.17816/PAVLOVJ97131 EDN: UJFDEG
- Dobin VL, Gorbunov AV, Muratov EN. Clinical case of an unusual course of coronavirus infection in patient with chronic disseminated pulmonary tuberculosis and human immunodeficiency virus infection. I.P. Pavlov Russian Medical Biological Herald. 2021;29(4):539–543. doi: 10.17816/PAVLOVJ65124 EDN: HZGEPI
- Udwadia ZF, Vora A, Tripathi AR, et al. COVID-19 — Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020;67(4 Suppl): S155–S162. doi: 10.1016/j.ijtb.2020.07.003 EDN: VJSWGF
- Flores-Lovon K, Ortiz-Saavedra B, Cueva-Chicaña LA, et al. Immune responses in COVID-19 and tuberculosis coinfection: A scoping review. Front Immunol. 2022;13:992743. doi: 10.3389/fimmu.2022.992743 EDN: DJYDPL
- Kim SH, Jhun BW, Jeong B-H, et al. The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea. J Korean Med Sci. 2022;37(32):e250. doi: 10.3346/jkms.2022.37.e250 EDN: TVPOUL
- Masoumi M, Sakhae F, Vaziri F, et al. Reactivation of Mycobacterium simiae after the recovery of COVID-19 infection. J Clin Tuberc Other Mycobact Dis. 2021;24:100257. doi: 10.1016/j.jctube.2021.100257 EDN: KDBJZX
- Sookaromdee P, Joob B, Wiwanitkit V. COVID-19 coinfection with Mycobacterium abscessus: A note. Int J Mycobacteriol. 2022;11(3):339–340. doi: 10.4103/ijmy.ijmy_90_22 EDN: FEOTOR
补充文件
